课题基金 / 基金详情

Thyroid Follicular Cell Signaling and Development in Humans

Thyroid Follicular Cell Signaling and Development in Humans
人类甲状腺滤泡细胞信号传导和发育
批准号:
10298043
负责人:
ANTHONY N HOLLENBERG
金额:
$37.11万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
未结题
起止时间:
2015-12-01 至 2025-04-30

项目摘要

项目成果

ANTHONY N HOLLENBERG的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary The development of the thyroid gland from anterior endoderm is an essential step in development that allows for the production of thyroid hormones around week 12 in utero in humans. Unfortunately, in about 1/4000 births genetic mutations that affect this development pathway lead to congenital hypothyroidism requiring lifelong thyroid hormone replacement therapy. Thus, a better understanding of thyroid follicular cell development could lead to a process where genetic editing and cellular therapy could provide treatment for congenital hypothyroidism (CH). Our work in this area has utilized a directed differentiation approach and has identified bone morphogenic protein and fibroblast growth factor as key mediators of thyroid follicular cell lineage development across species resulting in functional murine thyroid follicular cells that can rescue athyreotic mice. In this proposal, we now turn our attention exclusively to human thyroid follicular cell development and propose three Specific Aims that will allow for the pre-clinical development of functioning human thyroid follicular cells derived from human induced pluripotent stem cells (iPSCs), In the first Aim we will utilize a novel lineage tracing methodology to understand how developing human thyroid follicular acquire their cell fate and to ensure that the process in iPSC parallels that in vivo. In the second Aim we will prove that the human thyroid follicular cells derived from iPSCs are fully able to produce thyroid hormones in vitro and can be transplanted into immunodeficient athyreotic mice to rescue their hypothyroidism. Finally, in the third Aim we will demonstrate pre- clinically that derived iPSCs from a patient with CH can be genetically corrected and re-introduced via transplant to function normally. Together completion of these Aims will provide key insight into the possibilities of iPSC derived cellular therapy for the treatment of CH and enhance our understanding of the development endodermal- derived tissues in humans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Thyroid Hormone Signaling in Human Hepatocytes
  • 批准号:
    10874207
  • 项目类别:
  • 资助金额:
    $33.63万
  • 财政年份:
    2023
  • 负责人:
    ANTHONY N HOLLENBERG
  • 依托单位:
Thyroid Follicular Cell Signaling and Development in Humans
  • 批准号:
    10801642
  • 项目类别:
  • 资助金额:
    $41.25万
  • 财政年份:
    2023
  • 负责人:
    ANTHONY N HOLLENBERG
  • 依托单位:
Hypothalamic regulation by thyroid hormone receptor phosphorylation
Corepressor regulation of nuclear receptor action
  • 批准号:
    10562608
  • 项目类别:
  • 资助金额:
    $13.22万
  • 财政年份:
    2022
  • 负责人:
    ANTHONY N HOLLENBERG
  • 依托单位:
海外基金